Severe asthma presents a major challenge to health care and negatively affects the quality of life of patients. Understanding the factors predicting the development of severe asthma is limited.
Sublingual immunotherapy (SLIT) is a safe, effective therapy for the treatment of food allergy. Studies demonstrating SLIT efficacy have primarily used pharmaceutical glycerinated food extracts…
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
Oral Immunotherapy (OIT) has exhibited great potential in the treatment of food allergy. However, there is no global consensus on best practices of OIT. Parents…
Knowledge and understanding of mast cell biology and mast cell disorders has increased in the past several years, with new classifications of diseases for both…
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
The past decade has seen a proliferation in biologic therapies for moderate to severe asthma, with 5 therapies gaining US Food and Drug Administration (FDA)…
Chronic rhinosinusitis is a common inflammatory condition that often leads to significant sleep disturbances, negatively affecting quality of life. Although intranasal steroids are a standard…
Mast cell activation syndrome (MCAS) is a heterogeneous, uncommon entity presenting with acute, recurrent episodes of severe systemic symptoms, which may have clonal or nonclonal…
Patients with chronic rhinosinusitis with nasal polyps comorbid with asthma often experience poor outcomes after endoscopic sinus surgery.
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
